ois.white-logo

CELEBRATING 10 YEARS OF INNOVATION

UPCOMING EVENTS

Uniting the Key People to Drive & Foster Ophthalmic Innovation

OCTOBER 24, 2018

CHICAGO, IL

OCTOBER 25, 2018

CHICAGO, IL

UPCOMING EVENTS

Uniting the Key People to Drive & Foster Ophthalmic Innovation

OCTOBER 24, 2018

CHICAGO, IL

OCTOBER 25, 2018

CHICAGO, IL

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

Preceyes Takes Robotic Surgery Platform, Trial Results to Euretina and AAO

Preceyes Takes Robotic Surgery Platform, Trial Results to Euretina and AAO

Netherlands-based Preceyes BV seems to have taken the lead in the race to develop a robotic platform for retinal surgery as it prepares to demonstrate ...
MIGS Minus One: What’s Next?

MIGS Minus One: What’s Next?

With Alcon’s voluntary withdrawal in late August of the CyPass MicroStent due to safety concerns, many have been wondering how the rest of the class ...
Glaukos and STAAR Drive OIS Index into Record Territory

Glaukos and STAAR Drive OIS Index into Record Territory

The OIS Index of ophthalmic stocks surged to new highs in August, driven by two of the highest-weighted stocks in the index. The OIS Index ...
First US-Approved Nerve Growth Factor is for the Eye

First US-Approved Nerve Growth Factor is for the Eye

In the use of biological agents for treatment of eye disease, the back of the eye has been pretty much the sole domain thanks to ...
Novartis’ Plans for Brolucizumab and Beyond

Novartis’ Guerard Shares Plans for Brolucizumab, Lucentis, Gene Therapy, and FocalView App

Coming off the positive feedback at the American Society of Retina Specialists meeting to trial results of the investigative anti-VEGF agent brolucizumab, Frederic Guerard, Novartis’ ...
Gene Therapy Treatments Are Filling Some Companies’ Pipelines

Gene Therapy Treatments Are Filling Some Companies’ Pipelines

Major pharma companies in ophthalmology aren’t the only ones making plays in the gene therapy space, as we reported last week. Mid-size and small companies ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.